title: Impact of primary immunosuppression on the incidence of infectious complications after orthotopic liver transplantation.
authors: Department of Surgery, Charité Campus Virchow-Klinikum, Humboldt University Berlin, Berlin, Germany.
authors: R
authors: R
authors: Lohmann
authors: J M
authors: JM
authors: Langrehr
authors: R
authors: R
authors: Raakow
authors: S
authors: S
authors: Jonas
authors: J
authors: J
authors: Klupp
authors: T
authors: T
authors: Steinmüller
authors: R
authors: R
authors: Neuhaus
authors: P
authors: P
authors: Neuhaus
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006085:Graft Survival; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D015994:Incidence; D007239:Infections / Q000453:epidemiology*; D016031:Liver Transplantation / Q000276:immunology*; D008297:Male; D011183:Postoperative Complications / Q000453:epidemiology*; D011239:Prednisolone / Q000627:therapeutic use; D012189:Retrospective Studies; D013997:Time Factors
chemical_list: D000911:Antibodies, Monoclonal; D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D011239:Prednisolone; C079843:inolimomab; D001379:Azathioprine